Lindbrook Capital, LLC Prothena Corp Public LTD CO Transaction History
Lindbrook Capital, LLC
- $1.09 Billion
- Q4 2024
A detailed history of Lindbrook Capital, LLC transactions in Prothena Corp Public LTD CO stock. As of the latest transaction made, Lindbrook Capital, LLC holds 677 shares of PRTA stock, worth $10,534. This represents 0.0% of its overall portfolio holdings.
Number of Shares
677
Previous 103
557.28%
Holding current value
$10,534
Previous $1,000
800.0%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding PRTA
# of Institutions
198Shares Held
44.5MCall Options Held
601KPut Options Held
259K-
Eco R1 Capital, LLC San Francisco, CA11.6MShares$180 Million7.5% of portfolio
-
Wellington Management Group LLP Boston, MA5.13MShares$79.8 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.86MShares$60 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.69MShares$57.3 Million0.01% of portfolio
-
Armistice Capital, LLC New York, NY2.24MShares$34.8 Million0.44% of portfolio
About PROTHENA CORP PUBLIC LTD CO
- Ticker PRTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,922,800
- Market Cap $730M
- Description
- Prothena Corporation plc, a late-stage clinical company, focuses on discovery and development of novel therapies for life-threatening diseases in the United States. The company is involved in developing Birtamimab, an investigational humanized antibody that is in Phase III clinical trial for the treatment of AL amyloidosis; Prasinezumab, a human...